Faeth Therapeutics, Inc. (FTH) vs WAVE Life Sciences Ltd. (WVE)

Faeth Therapeutics, Inc. and WAVE Life Sciences Ltd. are both Biotechnology companies. Faeth Therapeutics, Inc. and WAVE Life Sciences Ltd. are of similar size ($780.3M and $750.7M). Faeth Therapeutics, Inc. has the higher net margin (0.00% vs −309.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Faeth Therapeutics, Inc. leads on 8 and WAVE Life Sciences Ltd. on 4.

Valuation

Metric FTH WVE Biotechnology median
P/E n/m n/m 7.88
P/S n/m 11.80 11.47
P/B 0.91 1.70 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.13 n/m 0.74
EV/Sales n/m 4.71 10.73
Earnings yield (505.89%) (28.84%) (28.84%)
Free cash flow yield (21.43%) (25.05%) (23.03%)

Profitability

Metric FTH WVE Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (333.36%) 0.00%
Net margin 0.00% (309.73%) 0.00%
Free cash flow margin 0.00% (295.46%) 0.00%
Return on equity (195.26%) (68.31%) (57.72%)
Return on assets (176.88%) (49.95%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FTH WVE Biotechnology median
Revenue growth (TTM) — (30.42%) 5.64%
EPS growth (last fiscal year) 30.33% (72.86%) —
Revenue growth, 5-year CAGR — 16.31% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTH WVE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.69 9.99 4.73
Net debt to EBITDA 0.96 2.92 0.96

Dividend

Metric FTH WVE Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FTH WVE Biotechnology median
Market cap 750.66m 780.31m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack